Clinical Trial Update: Cooling in Mild Encephalopathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing cooling therapy for neonatal encephalopathy due to newborn asphyxia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Encephalopathy
• Newborn Asphyxia

Snippet

Sponsor: Imperial College London | Conditions: Neonatal Encephalopathy, Newborn Asphyxia | Phase 3 | Status: RECRUITING